Previous close | 2.9700 |
Open | 2.9700 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's range | 2.9700 - 2.9700 |
52-week range | 2.9700 - 5.3900 |
Volume | |
Avg. volume | 3,731 |
Market cap | 6.173B |
Beta (5Y monthly) | 1.04 |
PE ratio (TTM) | 5.64 |
EPS (TTM) | 0.5270 |
Earnings date | N/A |
Forward dividend & yield | 0.16 (5.52%) |
Ex-dividend date | 19 May 2022 |
1y target est | N/A |
The expansion will create 800 new retail jobs.
Liminal BioSciences Inc. (NASDAQ: LMNL) ("Liminal BioSciences" or the "Company"), today announced that it plans to report its first quarter 2022 financial results after market close on May 10, 2021. Liminal will host a conference call and webcast to discuss financial results at 8:30 am (ET) on Wednesday May 11, 2022.
Like-for-like sales rose more than 22% in Kingfisher's second half results.